Brand name: Molnupivir
Composition:
Each tablet contains:
Molnupiravir……………………………………….200mg
Indication:
• Mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness.
Dosage:
• Take 4 capsules 2 times a day (12 h interval) for 5 days. Do not take for more than 5 days.
Contraindications:
• Do not use in people allergic to this drug.
Warning:
• Administer as soon as possible after a diagnosis of COVID-19 has been made.
• Do not take during pregnancy.
• Men and women of childbearing potential should use effective contraception for the duration of treatment and for at least 3 months after the last dose of Molnupivir.
• Breast-feeding mothers should pump and discard breast milk during treatment and for 4 days after the last dose of Molnupivir.
• Not for use in patients under 18 years of age.
Adverse effects:
• Diarrhea, nausea, dizziness and headache.
Dosage form: red capsules 200mg.
Expiry date：24 months after date of manufacture.
Packaging: 40 capsules per bottle.
Storage:
• Keep in a dark and dry place and keep out of reach of children.
DISCLAIMER
The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
For your safety:
Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.
